PORTFOLIO NEWS BlackThorn Therapeutics Announces R&D Updates Jan 4, 2019 eGenesis Appoints William Westlin, Ph.D., as Executive Vice President of Research & Development Dec 15, 2018 Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL201 for Parkinson’s Disease Dec 10, 2018 AiCure’s Revenue Soars as it Bolsters Client List and Executive Team Dec 3, 2018 New AAN Collaboration with Verana Health Dec 1, 2018 COMPASS THERAPEUTICS ANNOUNCES PRECLINICAL DATA ON LEAD ANTIBODY PROGRAM AND NK CELL ENGAGER PLATFORM TO BE PRESENTED AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER ANNUAL MEETING Nov 6, 2018 BlackThorn Therapeutics Names Bill Martin, Ph.D., President and Chief Operating Officer Nov 5, 2018 Twist Bioscience Corporation Announces Pricing of Initial Public Offering Oct 31, 2018 Twist Bioscience Adds Ray Tabibiazar, M.D., as Senior Vice President, Corporate Development and Business Strategy Oct 24, 2018 BlackThorn Therapeutics Announces Participation in Key Data Science and Cloud Computing Panels to Advance Therapeutic Development at 2018 BIO Investor Forum Oct 11, 2018 « Older Entries Next Entries » PORTFOLIO PRESS COVERAGE GeekWire: UW, Microsoft and Twist Bioscience double down on DNA data storage experiments Apr 17, 2017 MedCityNews: Study of medication adherence with AI-supported selfies highlights potential for clinical trials Apr 8, 2017 TechRepublic: New study shows how AI can improve recovery in stroke patients Apr 7, 2017 mobiHealthNews: In small study, AiCure app led to 50 percent improvement in medication adherence Apr 7, 2017 Boston Business Journal: Thiel-backed Cambridge biotech preps launch after closing $170M round Mar 29, 2017 Science Magazine: DNA could store all of the world’s data in one room Mar 2, 2017 MedCity News: Cambridge-based Compass Therapeutics raising $120M for antibody discovery work Jul 8, 2015 Next Entries »
eGenesis Appoints William Westlin, Ph.D., as Executive Vice President of Research & Development Dec 15, 2018
Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL201 for Parkinson’s Disease Dec 10, 2018
COMPASS THERAPEUTICS ANNOUNCES PRECLINICAL DATA ON LEAD ANTIBODY PROGRAM AND NK CELL ENGAGER PLATFORM TO BE PRESENTED AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER ANNUAL MEETING Nov 6, 2018
Twist Bioscience Adds Ray Tabibiazar, M.D., as Senior Vice President, Corporate Development and Business Strategy Oct 24, 2018
BlackThorn Therapeutics Announces Participation in Key Data Science and Cloud Computing Panels to Advance Therapeutic Development at 2018 BIO Investor Forum Oct 11, 2018
GeekWire: UW, Microsoft and Twist Bioscience double down on DNA data storage experiments Apr 17, 2017
MedCityNews: Study of medication adherence with AI-supported selfies highlights potential for clinical trials Apr 8, 2017
mobiHealthNews: In small study, AiCure app led to 50 percent improvement in medication adherence Apr 7, 2017
Boston Business Journal: Thiel-backed Cambridge biotech preps launch after closing $170M round Mar 29, 2017
MedCity News: Cambridge-based Compass Therapeutics raising $120M for antibody discovery work Jul 8, 2015
